Discover out about Palforzia® peanut oral immunotherapy exiting the market worldwide, and get the most recent updates on sublingual epinephrine movie. Discover out how one can take part in a analysis alternative for youngsters with tree nut allergy. Plus, learn our mythbuster on co-factors and allergic reactions.
Analysis: Palforzia® peanut oral immunotherapy powder exiting the market worldwide
Palforzia®, an oral powder prescription immunotherapy remedy for youngsters with peanut allergy, is exiting the market worldwide. Producer Stallergenes Greer is discontinuing the commercialization of the remedy as of July 31, 2026, and has famous that this voluntary discontinuation is just not associated to product security, high quality, or efficacy. This exit principally impacts the U.S., U.Ok., and a few European international locations.
Please notice, this product was not out there in Canada; Canadian allergists advocate utilizing actual meals for oral immunotherapy.
Analysis: U.S. FDA assessment of under-the-tongue (sublingual) epinephrine movie
The U.S. Meals and Drug Administration (FDA) has requested for extra info earlier than approving Anaphylm™, an under-the-tongue (sublingual) epinephrine movie being developed to deal with anaphylaxis.
In its response, the FDA raised issues about how simple the product is to make use of in an emergency — together with opening the package deal and putting the movie appropriately below the tongue. The FDA additionally requested extra analysis to grasp how any adjustments to the packaging or directions would possibly have an effect on use.
Aquestive Therapeutics, the corporate growing Anaphylm™, says it expects to deal with these points rapidly and plans to resubmit its software to the FDA later this yr. It additionally plans to use for approvals in Europe and Canada by the tip of the yr.
We’ll proceed to share updates on the standing of recent remedy choices internationally and on our advocacy efforts for entry to epinephrine system choices in Canada.
Analysis examine: Name for participation for youngsters with tree nut allergy
A analysis examine is underway in Hamilton, Ontario. The researchers are searching for kids aged 1-16 years who’ve been identified with tree nut allergy, particularly to cashew, pistachio, walnut, pecan, almond, or hazelnut.
The examine is testing totally different immunotherapies to desensitize an individual with tree nut allergy by repeated exposures to very small quantities of tree nut via sublingual immunotherapy (SLIT) or low-dose oral immunotherapy (IdOIT). SLIT is when a meals allergen is positioned below the tongue and OIT is when a meals allergen is eaten.
Meals Allergy Canada is concerned on this analysis via a affected person/caregiver partnership the place we offer enter on the design of the analysis, assessment analysis outcomes, and make sure the affected person perspective is taken into account.
Learn extra particulars in regards to the examine from the analysis workforce. To study extra in regards to the examine and in case your youngster is eligible to take part, full this type or e mail [email protected].
Please share with others whose kids have tree nut allergy.
Mythbuster: Can co-factors have an effect on how somebody would possibly react to their meals allergen?
FACT: Sure, co-factors can decrease the edge, the quantity of the allergen at which one reacts, or can pace up the development of a response, making it extra extreme. Widespread co-factors embody train, sickness, and uncontrolled bronchial asthma.
It’s necessary to pay attention to potential co-factors and take them into consideration when managing your meals allergy. As all the time, be conversant in the signs of anaphylaxis and ready with epinephrine if a response occurs.
Be taught extra
Assist us educate your communities and share this mythbuster with them! Discover extra mythbusters at foodallergycanada.ca/mythbusters.
Tags: advocacy, Anaphylm, cofactors, mythbuster, Palforzia, analysis examine, TRADE examine
